Key facts
- This page summarizes John Hernandez's Form 4 filing for RESMED INC (RMD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Aug 2025, 13:10.
John Hernandez - 18 Aug 2025 Form 4 Insider Report for RESMED INC (RMD)
- Reporting relationship
- Director
- Issuer ticker
- RMD
- Reported as of
- 18 Aug 2025
- Net transaction value
- -$355,872
- SEC form
- 4
- Accepted by SEC
- 19 Aug 2025, 13:10:30 UTC
- Prior SEC filing
- 22 Nov 2024
- Next SEC filing
- 24 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- John Hernandez, Director
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Hernandez filed Form 4 for RESMED INC (RMD) on 19 Aug 2025.
Change
- Previous filing in this sequence was filed on 22 Nov 2024.
- Current net transaction value: -$355,872.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001890555
Primary reporting owner
Hernandez John
- Relationship
- Director
- Address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO
- Signature
- John Hernandez, Director
- Signature date
- 19 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMD
transaction
ResMed Common Stock
Options Exercise
- Transaction value
- $383,418
- Shares
- +2,575
- Change %
- +64%
- Price
- $148.90
- Shares after
- 6,620
- Date
- 18 Aug 2025
- Ownership
- Direct
RMD
transaction
ResMed Common Stock
Sale
- Transaction value
- $739,289
- Shares
- -2,575
- Change %
- -39%
- Price
- $287.10
- Shares after
- 4,045
- Date
- 18 Aug 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RMD
transaction
Derivative
ResMed Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -2,575
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Aug 2025
- Ownership
- Direct
- Underlying class
- ResMed Common Stock
- Underlying amount
- 2,575
- Exercise price
- $148.90
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This transaction was executed in multiple trades at prices ranging from $286.90 - $287.24. The price reported above reflects the weighted average sale price.
Footnote F2
Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.